_________ false
àáåâï áò"î 2 381
EVOGENE LTD
Corporation no: 512838723 10571

Israel Securities Authority   Tel Aviv Stock Exchange   C003 ( Public )   Reported via MAGNA: 01/05/2018
  www.isa.gov.il     www.tase.co.il       Reference: 2018-02-043243 Time of broadcast: 13:54 13:45:22

Other Report or Announcement
Regulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000


Delay the publication of a report _________ _________
1. The delay of the report can be done up to 72 hours maximum from the date of filling out the form.
2. Attention that in accordance with the provisions of the law, the reporting date must be simultaneous with the report in the foreign exchange.


The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on
Biomica_focus_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
       

Stock Exchange/Market: -1 Date of revision of form structure: 20/02/2018
Address: Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121   , Tel: 08-9311900 , Fax: 08-9466724
E-mail address: ofer.haviv@evogene.com   Company site: www.evogene.com

Previous names of reporting entity:

Name of the Signatory: Masliah Sassi Position of Signatory in the reporting corporation: Director of Legal Affairs & Company Secretary Name of Employer Company:
Address: Gad Feinstein 13 , Rehovot 7612001 Telephone: 08-9311901 Facsimile: 08-9466724 E-mail: sassi.masliah@evogene.com 1